1-3 of 3
Wolfgang Miesbach
Close
Sort by
Journal Articles

ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP

Clinical Trials & Observations
Linus A. Völker, Jessica Kaufeld, Wolfgang Miesbach, Sebastian Brähler, Martin Reinhardt, Lucas Kühne, Anja Mühlfeld, Adrian Schreiber, Jens Gaedeke, Markus Tölle, Wolfram J. Jabs, Fedai Özcan, Silke Markau, Matthias Girndt, Frederic Bauer, Timm H. Westhoff, Helmut Felten, Martin Hausberg, Marcus Brand, Jens Gerth, Markus Bieringer, Martin Bommer, Stefan Zschiedrich, Johanna Schneider, Saban Elitok, Alexander Gawlik, Anja Gäckler, Andreas Kribben, Vedat Schwenger, Ulf Schoenermarck, Maximilian Roeder, Jörg Radermacher, Jörn Bramstedt, Anke Morgner, Regina Herbst, Ana Harth, Sebastian A. Potthoff, Charis von Auer, Ralph Wendt, Hildegard Christ, Paul T. Brinkkoetter, Jan Menne
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3093–3101.
https://doi.org/10.1182/bloodadvances.2020001987
Published: 2020
Includes: Supplemental data
Journal Articles

Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura

Clinical Trials & Observations
Linus A. Völker, Jessica Kaufeld, Wolfgang Miesbach, Sebastian Brähler, Martin Reinhardt, Lucas Kühne, Anja Mühlfeld, Adrian Schreiber, Jens Gaedeke, Markus Tölle, Wolfram J. Jabs, Fedai Özcan, Silke Markau, Matthias Girndt, Frederic Bauer, Timm H. Westhoff, Helmut Felten, Martin Hausberg, Marcus Brand, Jens Gerth, Markus Bieringer, Martin Bommer, Stefan Zschiedrich, Johanna Schneider, Saban Elitok, Alexander Gawlik, Anja Gäckler, Andreas Kribben, Vedat Schwenger, Ulf Schoenermarck, Maximilian Roeder, Jörg Radermacher, Jörn Bramstedt, Anke Morgner, Regina Herbst, Ana Harth, Sebastian A. Potthoff, Charis von Auer, Ralph Wendt, Hildegard Christ, Paul T. Brinkkoetter, Jan Menne
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3085–3092.
https://doi.org/10.1182/bloodadvances.2020001973
Published: 2020
Includes: Supplemental data
Journal Articles

Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B

Annette Von Drygalski, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan Lattimore, Frank W. G. Leebeek, Wolfgang Miesbach, Michael Recht, Alison Long, Robert Gut, Eileen K. Sawyer, Steven W. Pipe
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3241–3247.
https://doi.org/10.1182/bloodadvances.2019000811
Published: 2019
Includes: Supplemental data